In the late 1950s, a new over-the-counter sedative, thalidomide was introduced in Germany. At the time, it was the only non-barbiturate sedative on the market and it was marketed as an extraordinarily safe sleeping aid. The drug company “advertised their product as ‘completely safe’ for everyone, including mother and child, ‘even during pregnancy,’ as its […]
The Commissioner of the United States Food and Drug Administration, Margaret Hamburg will provide the keynote address to the O’Neill Institute for National and Global Health Law’s Summer Program on Emerging Issues in Food and Drug Law. Margaret A. Hamburg became the 21st commissioner of food and drugs on May 18, 2009. The second woman […]
A committee formed by the Institute of Medicine (IOM), National Academy of Science, and chaired by O’Neill Institute for National and Global Health Law Faculty Director and Georgetown University Law Center Professor Lawrence Gostin has issued a new report, “Countering the Problem of Falsified and Substandard Drugs,” which offers recommendations to the United States and […]
Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute
Or sign up for our RSS Feed
The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.